Therapeutic Targeting of Cancer: Epigenetic Homeostasis

Xiaoyuan Yu1, Menglu Li2, Chunyan Guo1

  • 1Department of Oncology, First Hospital of Shanxi Medical University, Taiyuan, China.

Frontiers in Oncology
|November 12, 2021
PubMed

Insights

Epigenetics is crucial in cancer, but current drugs lack lasting effects. Redefining epigenetics

Area of Science:

  • Oncology
  • Epigenetics
  • Developmental Biology

Background:

  • Epigenetics is increasingly recognized for its significant role in cancer development.
  • Current epigenetic drugs show limitations in achieving stable curative effects.
  • Embryonic development and tumor development share similarities in biological behavior and molecular patterns, suggesting epigenetics as a potential link.

Purpose of the Study:

  • To introduce the importance of epigenetic homeostasis in cancer development.
  • To analyze the shortcomings of current epigenetic treatment regimens.
  • To propose a new perspective on cancer characterization and treatment by understanding epigenetic homeostasis.

Main Methods:

  • Review of existing literature on epigenetics, cancer development, and embryonic development.
  • Analysis of the similarities in biological behavior and molecular expression patterns between embryonic and tumor development.
  • Discussion on the concept of epigenetic homeostasis at the cellular level and its role in cell differentiation.

Main Results:

  • Epigenetic homeostasis is vital for normal organ development and is disrupted in cancer.
  • Current epigenetic therapies are insufficient due to a lack of understanding of the dynamic nature of epigenetic regulation.
  • Cancer can be better understood and potentially treated by considering its differentiation stages linked to epigenetic homeostasis.

Conclusions:

  • Understanding epigenetic homeostasis in organ development offers a new framework for cancer research.
  • This approach may lead to the identification of novel therapeutic targets and improved treatment strategies for cancer.
  • Characterizing cancer based on differentiation stages influenced by epigenetic homeostasis can enhance clinical prognosis.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K